Compare LGCB & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGCB | PAVM |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | Japan | United States |
| Employees | N/A | 107 |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1M | 8.7M |
| IPO Year | 2023 | N/A |
| Metric | LGCB | PAVM |
|---|---|---|
| Price | $1.55 | $10.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $510.00 |
| AVG Volume (30 Days) | 22.4K | ★ 31.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.21 |
| 52 Week High | $3.10 | $28.44 |
| Indicator | LGCB | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 49.79 | 52.12 |
| Support Level | $1.43 | $0.38 |
| Resistance Level | $2.23 | $10.98 |
| Average True Range (ATR) | 0.11 | 0.70 |
| MACD | -0.01 | -0.13 |
| Stochastic Oscillator | 49.38 | 55.09 |
Linkage Global Inc is a cross-border e-commerce integrated service provider. It provides international e-commerce merchants, overseas brands, import and export trading enterprises, etc. with a globally selected supply chain, digital marketing, e-commerce training, international store, ERP and e-commerce software, social e-commerce and other e-commerce integrated services. The company has two operating segments: Extend from Japan, and Other Subsidiaries from Hong Kong. The company is Committed to building a one-stop cross-border integrated service platform to make cross-border trade easier. Company operates in Japan, Hong Kong and China, with maximum revenue from Japan.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.